Clinical Trial Update: Bifidobacterium Animalis Subsp. Lactis for Lowering the Risk of Common Infections in Hospitalized Children [NA]

View source ↗

Summary

A completed clinical trial evaluated the probiotic Bifidobacterium animalis subsp. lactis for reducing the risk of common infections in hospitalized children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Tract Infections
• Respiratory Tract Infections

Drugs mentioned

• Bifidobacterium animalis subsp. lactis (Bifidobacterium animalis subsp. lactis)

Snippet

Sponsor: Children's Hospital Zagreb | Conditions: Gastrointestinal Tract Infections, Respiratory Tract Infections | NA | Status: COMPLETED